Halma (LON:HLMA – Get Free Report)‘s stock had its “equal weight” rating restated by equities researchers at Barclays in a research note issued on Monday, Digital Look reports. They currently have a GBX 2,425 ($29.78) price objective on the stock. Barclays‘s price target suggests a potential upside of 16.04% from the company’s previous close.
Separately, Shore Capital restated a “buy” rating on shares of Halma in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of GBX 2,230 ($27.39).
Halma Price Performance
Insiders Place Their Bets
In other Halma news, insider Steve Gunning acquired 1,551 shares of the firm’s stock in a transaction on Friday, September 22nd. The stock was purchased at an average cost of GBX 1,934 ($23.75) per share, for a total transaction of £29,996.34 ($36,836.96). Corporate insiders own 2.03% of the company’s stock.
Halma Company Profile
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical.
- Five stocks we like better than Halma
- How to Invest in the FAANG Stocks
- The most upgraded stocks in November have two things in common
- Why Consider Investing in Nanotechnology Stocks
- Monday.com rocked earnings like it’s the weekend
- The Most Important Warren Buffett Stock for Investors: His Own
- Plan to own one retailer? Make it this one
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.